Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.280
+0.070 (5.79%)
At close: Aug 13, 2025, 4:00 PM
1.300
+0.020 (1.56%)
After-hours: Aug 13, 2025, 6:50 PM EDT
PACB Employees
Pacific Biosciences of California had 575 employees as of December 31, 2024. The number of employees decreased by 221 or -27.76% compared to the previous year.
Employees
575
Change (1Y)
-221
Growth (1Y)
-27.76%
Revenue / Employee
$271,496
Profits / Employee
-$915,407
Market Cap
384.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PACB News
- 4 days ago - Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - PacBio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models - GlobeNewsWire
- 15 days ago - Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing - PRNewsWire
- 20 days ago - PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications - GlobeNewsWire
- 21 days ago - PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio - GlobeNewsWire
- 23 days ago - PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 2 months ago - Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date - PRNewsWire